Therapeutic effects of histone deacetylase inhibitors on kidney disease. (Q48136812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

review article

1 reference

title

Therapeutic effects of histone deacetylase inhibitors on kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Pusoon Chun

series ordinal

1

1 reference

9 February 2018

http://europepmc.org/abstract/MED/29230688

publication date

11 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

Archives of Pharmacal Research

7 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

162-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

p21 in cancer: intricate networks and multiple activities

7 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The promise of retinoids to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The role of podocytes in glomerular pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inside HDAC with HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

HDAC inhibitors in kidney development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

JAK inhibition and progressive kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Sirtuin functions and modulation: from chemistry to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Up-Regulation of SIRT1 Reduces Endoplasmic Reticulum Stress and Renal Fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase inhibitors in hematological malignancies and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Effects of histone deacetylase inhibitors on rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The JNK Signaling Pathway in Renal Fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The complexity of NF-κB signaling in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Genetics and pathogenesis of polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

HES and HERP families: multiple effectors of the Notch signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Therapeutic activity of the histone deacetylase inhibitor SB939 on renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

A novel hydroxamic acid derivative, MHY218, induces apoptosis and cell cycle arrest through downregulation of NF-κB in HCT116 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Signaling through the JAK/STAT pathway, recent advances and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Redox regulation of FoxO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Wnt signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Induction of p21CIP1 protein and cell cycle arrest after inhibition of Aurora B kinase is attributed to aneuploidy and reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

A novel gamma-lactam-based histone deacetylase inhibitor potently inhibits the growth of human breast and renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Potential role of Akt signaling in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Therapeutic targets for treating fibrotic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Class-specific histone/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Targeting Sirtuin-1 prolongs murine renal allograft survival and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Role of transcription factor acetylation in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Signalling pathways involved in hypoxia-induced renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Transforming growth factor-β and the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

TGF-β: the master regulator of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

T cell subsets and their signature cytokines in autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Signal integration in the endoplasmic reticulum unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

ERK1/2 MAP kinases: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Structural, functional and therapeutic biology of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

NF-kappaB in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Complex inhibitory effects of nitric oxide on autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Combination of suberoylanilide hydroxamic acid and ritonavir is effective against renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Antitumor effect of suberoylanilide hydroxamic acid and topotecan in renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

p53 and cell cycle effects after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The story of Notch and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Nonhistone protein acetylation as cancer therapy targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

TGF-β signaling in the kidney: profibrotic and protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Regulatory T-cell therapy in transplantation: moving to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Retinoids, Retinoic Acid Receptors, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Role of epidermal growth factor receptor in acute and chronic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Class I HDAC activity is required for renal protection and regeneration after acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Smad mediated regulation of inhibitor of DNA binding 2 and its role in phenotypic maintenance of human renal proximal tubule epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Co-regulation of Gremlin and Notch signalling in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Transforming growth factor-beta and Smad signalling in kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Bone Morphogenetic Protein (BMP) signaling in development and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

SIRT1 Protects Against Oxidative Stress-Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Skp2 is required for Aurora B activation in cell mitosis and spindle checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3+IL-17+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

AN INHIBITOR OF HISTONE DEACETYLASE 6 ACTIVITY, ACY-1215, REDUCES cAMP and CYST GROWTH IN POLYCYSTIC KIDNEY DISEASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Histone deacetylases augment cytokine induction of the iNOS gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

TGF-beta isoforms in renal fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Regulation of STAT signaling by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

Renal Bone Morphogenetic Protein-7 Protects against Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-017-0998-7

10.1007/S12272-017-0998-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230688%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference